October 25, 2021
  • CMS released new guidance requiring state Medicaid programs and the Children’s Health Insurance Program to cover treatments for COVID-19 without cost sharing. The coverage requirement includes drugs approved by the FDA for treating COVID-19, preventive therapies, specialized equipment, and treatments for long COVID-19 conditions. States also are required to cover treatments for conditions that may complicate the treatment of COVID-19, if those conditions are otherwise covered under the state plan. (Press release here)